RBSE Board Exam 2026 schedule released for Classes 9, 10, 11 & 12. Class 10 & 12 exams from 12 Feb to 12 Mar, Class 9 & 11 from 10 Mar to 25 Mar. Check complete timetable, important instructions, and ...

D3 Bio, a global clinical-stage biotechnology company focused on the discovery and development of innovative oncology therapeutics, announced the completion of a $108 million Series B financing round.

ISC Biology Specimen Paper 2026 Class 12 helps students understand exam pattern, important topics, and marking scheme for the ...

Second FDA designation for SENTI-202 this year, after Orphan Drug Designation, is supported by clinical data showing deep and durable complete remission rates combined with a well-tolerated safety ...

ASH 2025 oral presentation on SENTI-202 in 20 Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) patients (18 response evaluable) shows high efficacy: 50% ORR and 42% CR/CRh (100% of CRs and 83% of ...

SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune diseases, ...

Class 10 and 12 theory exams start on February 17 with English and cover major subjects like Mathematics, Physics, and ...

One is a seasoned sports and entertainment executive. The other has cut a long trail of tech involvement. Together, they now ...

MIAMI, Dec. 08, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: SABS ), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmu ...

Upstream Bio, Inc.'s Verekitug shows phase 2 success in CRSwNP; unique dosing, pipeline catalysts, and solid cash position ...

ONC001 is a first-in-class antibody-drug conjugate (ADC) designed to uniquely target CD64, a myeloid-restricted receptor pervasively expressed in CMML and M4/M5 acute myeloid leukemia, including ...

SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Boundless Bio, (Nasdaq: BOLD) a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to ...